Terms: = Colorectal cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
125 results:
1. TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mtor pathway.
Chi XJ; Song YB; Zhang H; Wei LQ; Gao Y; Miao XJ; Yang ST; Lin CY; Lan D; Zhang X
Apoptosis; 2024 Aug; 29(7-8):1185-1197. PubMed ID: 38824479
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic factors and survival disparities in right-sided versus left-sided colon cancer.
Asghari-Jafarabadi M; Wilkins S; Plazzer JP; Yap R; McMurrick PJ
Sci Rep; 2024 May; 14(1):12306. PubMed ID: 38811769
[TBL] [Abstract] [Full Text] [Related]
3. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
[TBL] [Abstract] [Full Text] [Related]
4. Gentisic acid prevents colorectal cancer metastasis via blocking GPR81-mediated DEPDC5 degradation.
Feng G; Zhang L; Bao W; Ni J; Wang Y; Huang Y; Lyv J; Cao X; Chen T; You K; Khan H; Shen X
Phytomedicine; 2024 Jul; 129():155615. PubMed ID: 38615493
[TBL] [Abstract] [Full Text] [Related]
5. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mtor signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
6. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mtor pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
7. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
[TBL] [Abstract] [Full Text] [Related]
8. Bio Informatics Analysis of the Relationship Between Mammalian Target of Rapamycin and colorectal cancer.
Han L; Lin L; Chen J; Yan B
Stud Health Technol Inform; 2023 Nov; 308():322-328. PubMed ID: 38007756
[TBL] [Abstract] [Full Text] [Related]
9. ATGL promotes colorectal cancer growth by regulating autophagy process and SIRT1 expression.
Su BC; Xiao KM; Wang KL; Yang SF; Huang ZX; Luo JW
Med Oncol; 2023 Nov; 40(12):350. PubMed ID: 37935950
[TBL] [Abstract] [Full Text] [Related]
10. RFC2 promotes aerobic glycolysis and progression of colorectal cancer.
Lou F; Zhang M
BMC Gastroenterol; 2023 Oct; 23(1):353. PubMed ID: 37821801
[TBL] [Abstract] [Full Text] [Related]
11. Identification of autophagy and angiogenesis modulators in colorectal cancer based on bioinformatics analysis.
Shakeri F; Mohamadynejad P; Moghanibashi M
Nucleosides Nucleotides Nucleic Acids; 2024; 43(4):340-355. PubMed ID: 37791824
[TBL] [Abstract] [Full Text] [Related]
12. A Comprehensive Pan-cancer Analysis of the Potential Biological Functions and prognosis Values of RICTOR.
Sun Y; Li R; Nong B; Songyang Z; Wang X; Ma W; Zhou Q
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372460
[TBL] [Abstract] [Full Text] [Related]
13. Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mtor signaling pathway.
Zheng W; Guo Y; Zhang G; Bai J; Song Y; Song X; Zhu Q; Bao X; Wu G; Zhang C
PLoS One; 2023; 18(6):e0287133. PubMed ID: 37347740
[TBL] [Abstract] [Full Text] [Related]
14. DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mtor signaling pathway.
García-Moreno JF; Lacerda R; da Costa PJ; Pereira M; Gama-Carvalho M; Matos P; Romão L
Cell Mol Life Sci; 2023 Jun; 80(7):185. PubMed ID: 37340282
[TBL] [Abstract] [Full Text] [Related]
15. Sensitization of colon cancer cells to cisplatin by Fbxw7 via negative regulation of the Nox1-mtor pathway.
Huang G; Long K
Pathol Res Pract; 2023 Jul; 247():154479. PubMed ID: 37262995
[TBL] [Abstract] [Full Text] [Related]
16. NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mtor signaling pathway.
Zhu LL; Shi JJ; Guo YD; Yang C; Wang RL; Li SS; Gan DX; Ma PX; Li JQ; Su HC
Neoplasma; 2023 Apr; 70(2):272-286. PubMed ID: 37226932
[TBL] [Abstract] [Full Text] [Related]
17.
Byun J; Park NJ; Yoon G; Kang MK; Kim HJ; Park SY; Park JS; Choi GS; Baek JH; Kim JG; Seo AN
Anticancer Res; 2023 Apr; 43(4):1513-1520. PubMed ID: 36974808
[TBL] [Abstract] [Full Text] [Related]
18. colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: A review.
Ruan J; Zhang P; Zhang Q; Zhao S; Dang Z; Lu M; Li H; Zhang Y; Wang T
Int J Biol Macromol; 2023 May; 238():124165. PubMed ID: 36963537
[TBL] [Abstract] [Full Text] [Related]
19. Association of High LAT1 Expression with Poor prognosis and Recurrence in colorectal cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy.
Shibasaki Y; Yokobori T; Sohda M; Shioi I; Ozawa N; Komine C; Suga K; Nakazawa N; Osone K; Shiraishi T; Okada T; Sano A; Sakai M; Ogawa H; Kaira K; Shirabe K; Saeki H
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768934
[TBL] [Abstract] [Full Text] [Related]
20. G-protein signaling modulator 1 promotes colorectal cancer metastasis by PI3K/AKT/mtor signaling and autophagy.
Yang C; Yaolin S; Lu W; Wenwen R; Hailei S; Han Z; Xiaoming X
Int J Biochem Cell Biol; 2023 Apr; 157():106388. PubMed ID: 36758790
[TBL] [Abstract] [Full Text] [Related]
[Next]
